Fundraising Fox

Mitotherapeutix LLC

Woodbridge, US · Founded 2014 · Delaware LLC · 1 known investors

mitotherapeutix.com ↗

Mitotherapeutix develops siRNA-based drugs targeting mitochondrial metabolic regulation through RNA silencing. The company focuses on treating a broad range of diseases by modulating a metabolic regulator in the mitochondria.

AI & Machine LearningBiotechMedical Devices

Founders & leadership

RH
Robert HemleyExecutive Officer, Director
RH
Robert HennesseyExecutive Officer, Director
JV
John V. TalleyExecutive Officer, Director
FE
Fenel EloiDirector
DW
Daniel WagnerDirector

Investors · 1

Connecticut InnovationsNew Haven · $500K – $2M

Reported raises · per SEC filings

Form D private placements
▶$3MraisedMay 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Fenel EloiDirector
  • Robert HemleyExecutive Officer, Director
  • Robert HennesseyExecutive Officer, Director
  • John V. TalleyExecutive Officer, Director
  • Daniel WagnerDirector
Offering amount
$3M
Amount sold
$3M
First sale
Dec 2017
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30KraisedOct 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert HemleyExecutive Officer, Director
  • John TalleyExecutive Officer, Director
  • Robert HennesseyExecutive Officer, Director
Offering amount
$30K
Amount sold
$30K
First sale
Sep 2016
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.